55 related articles for article (PubMed ID: 38594753)
1. Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial.
Hashimoto T; Shiina A; Hasegawa T; Kimura H; Oda Y; Niitsu T; Ishikawa M; Tachibana M; Muneoka K; Matsuki S; Nakazato M; Iyo M
Ann Gen Psychiatry; 2016; 15():27. PubMed ID: 27777607
[TBL] [Abstract][Full Text] [Related]
2. [Use of antidepressant drugs in schizophrenic patients with depression].
Micallef J; Fakra E; Blin O
Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
[TBL] [Abstract][Full Text] [Related]
3. Vortioxetine for depression in adults.
Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
[TBL] [Abstract][Full Text] [Related]
4. Validation of the predictive value of BDNF -87 methylation for antidepressant treatment success in severely depressed patients-a randomized rater-blinded trial.
Maier HB; Neyazi A; Bundies GL; Meyer-Bockenkamp F; Bleich S; Pathak H; Ziert Y; Neuhaus B; Müller FJ; Pollmann I; Illig T; Mücke S; Müller M; Möller BK; Oeltze-Jafra S; Kacprowski T; Voges J; Müntefering F; Scheiber J; Reif A; Aichholzer M; Reif-Leonhard C; Schmidt-Kassow M; Hegerl U; Reich H; Unterecker S; Weber H; Deckert J; Bössel-Debbert N; Grabe HJ; Lucht M; Frieling H
Trials; 2024 Apr; 25(1):247. PubMed ID: 38594753
[TBL] [Abstract][Full Text] [Related]
5. DNA methylations of brain-derived neurotrophic factor exon VI are associated with major depressive disorder and antidepressant-induced remission in females.
Li L; Wang T; Chen S; Yue Y; Xu Z; Yuan Y
J Affect Disord; 2021 Dec; 295():101-107. PubMed ID: 34418778
[TBL] [Abstract][Full Text] [Related]
6. Scopolamine augmentation of a newly initiated escitalopram treatment for major depressive disorder: study protocol for a randomized controlled trial.
Zhou J; Wang W; Yang J; Zhu X; Feng L; Xiao L; Wang G
Trials; 2019 Jan; 20(1):33. PubMed ID: 30626409
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.
Wong ML; Dong C; Flores DL; Ehrhart-Bornstein M; Bornstein S; Arcos-Burgos M; Licinio J
Am J Psychiatry; 2014 Dec; 171(12):1297-309. PubMed ID: 25220861
[TBL] [Abstract][Full Text] [Related]
8. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
[TBL] [Abstract][Full Text] [Related]
9. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
10. BDNF exon IV promoter methylation and antidepressant action: a complex interplay.
Pathak H; Borchert A; Garaali S; Burkert A; Frieling H
Clin Epigenetics; 2022 Dec; 14(1):187. PubMed ID: 36572893
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysis.
Rhee TG; Shim SR; Forester BP; Nierenberg AA; McIntyre RS; Papakostas GI; Krystal JH; Sanacora G; Wilkinson ST
JAMA Psychiatry; 2022 Dec; 79(12):1162-1172. PubMed ID: 36260324
[TBL] [Abstract][Full Text] [Related]
12. Stratified psychiatry: Tomorrow's precision psychiatry?
Arns M; van Dijk H; Luykx JJ; van Wingen G; Olbrich S
Eur Neuropsychopharmacol; 2022 Feb; 55():14-19. PubMed ID: 34768212
[TBL] [Abstract][Full Text] [Related]
13. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.
Dean RL; Hurducas C; Hawton K; Spyridi S; Cowen PJ; Hollingsworth S; Marquardt T; Barnes A; Smith R; McShane R; Turner EH; Cipriani A
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011612. PubMed ID: 34510411
[TBL] [Abstract][Full Text] [Related]
14. Precision psychiatry.
Serretti A
Braz J Psychiatry; 2022; 44(2):115-116. PubMed ID: 34190828
[No Abstract] [Full Text] [Related]
15. The blurred line between anxiety and depression: hesitations on comorbidity, thresholds and hierarchy.
Demyttenaere K; Heirman E
Int Rev Psychiatry; 2020; 32(5-6):455-465. PubMed ID: 32436448
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
